Celyad Oncology SA (NASDAQ:CYAD)

BATS BZX Real-Time Price
As of Dec 02
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Celyad Oncology SA have a median target of 2.72, with a high estimate of 2.72 and a low estimate of 2.72. The median estimate represents a +171.93% increase from the last price of 1.00.

Chart unavailable

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Hold stock in Celyad Oncology SA. This rating has held steady since October, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.40%
Growthannually 22.58%


Growthquarterly -100.00%
Growthannually --
Key to the earnings and sales forecast charts.